Effect of 2-week treatment with pirenzepine on fasting and postprandial glucose concentrations in individuals with type 2 diabetes.
Issa
Basil G
BG
Davies
Nichola
N
Hood
Kerenza
K
Premawardhana
Lakdasa D K E
LD
Peters
John R
JR
Scanlon
Maurice F
MF
D001786:Blood Glucose / Q000378:metabolism*; D018592:Cross-Over Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D004311:Double-Blind Method; D005215:Fasting / Q000502:physiology*; D006801:Humans; D007328:Insulin / Q000097:blood; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D010890:Pirenzepine / Q000627:therapeutic use*
D001786:Blood Glucose; D007328:Insulin; D018727:Muscarinic Antagonists; D010890:Pirenzepine